H.Res. 1284 · 117th Congress
Of inquiry directing the Secretary of Health and Human Services to provide certain documentation to the House…
Full title
Of inquiry directing the Secretary of Health and Human Services to provide certain documentation to the House of Representatives relating to the negotiation of prices for prescription drugs under the Medicare prescription drug program.
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 117th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
McMorris RodgersSponsorNo cosponsors.
This resolution directs the Department of Health and Human Services (HHS) to furnish to the House of Representatives any external or internal communications of the White House regarding the implications of imposing certain penalties on drug manufacturers that do not comply with HHS price negotiations under the Medicare prescription drug benefit.
What it does: CRS summary · Reported to House · Sep 30, 2022
This resolution directs the Department of Health and Human Services (HHS) to furnish to the House of Representatives any external or internal communications of the White House regarding the implications of imposing certain penalties on drug manufacturers that do not comply with HHS price negotiations under the Medicare prescription drug benefit.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Of inquiry directing the Secretary of Health and Human Services to provide certain documentation to the House of Representatives relating to the negotiation of prices for prescription drugs under the Medicare prescription drug program.
Latest action (Sep 30, 2022): Placed on the House Calendar, Calendar No. 140.
Policy area: Health · Origin: House · Introduced: Jul 26, 2022
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.